Medical Device News Magazine

Carestream Shares Path to Accelerated Delivery of AI Features at HPE Discover 2022 Conference

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Carestream Health will share its path and commitment to delivering artificial-intelligence-powered features for medical imaging at the HPE Discover Edge-to-Cloud user conference June 28-30.

Carestream is the featured healthcare company at the conference, delivering a session on “Transforming Healthcare: Carestream Delivers AI with Edge-to-Cloud Platform” and participating in a panel on “Accelerating Your Transformation with the Cloud Experience Everywhere – From Customers Who Have.”

Carestream leverages HPE GreenLake’s enterprise-grade cloud service for machine learning (ML Ops platform) to accelerate development of its AI applications for medical imaging. The platform enables an accelerated workflow for research, including testing AI models on clinical data, getting faster feedback and deploying better solutions.

“Carestream is leveraging AI in our medical imaging solutions to develop new applications that help improve clinical outcomes and patient care, and accelerate workflow,” said Dharmendu Damany, Chief Technology Officer at Carestream. “HPE’s ML Ops platform helps us deliver our innovative solutions to the healthcare market more quickly.”

The HPE platform provides the massive computing power necessary to accelerate Carestream’s development of AI-powered imaging, workflow automation and analytics innovations. Case in point: Carestream had a significant reduction in the time to execute a training run for its AI-based Smart Noise Cancellation from ~60 hours to 16. Smart Noise Cancellation provides improved diagnostic quality, preservation of fine detail and better contrast-to-noise ratio for images acquired at clinically nominal exposures.*

“HPE gives us a platform to successfully manage the expanding scope and scale of our AI activities. Additionally, it frees up our imaging scientists to focus more time on creating solutions for our customers in healthcare and less energy on building the ‘plumbing’ needed for AI solution creation,” explained Mr. Damany.

Carestream’s presentation on “Transforming Healthcare: Carestream Delivers AI with Edge-to-Cloud Platform” will be delivered on Wednesday, June 29 at noon by John Kopcienski, Director, Systems Architecture and Platformed Components, and Mark Hourani, AI & Data Practice Lead at HPE. Mr. Kopcienski will join the panel discussion on “Accelerating Your Transformation with the Cloud Experience Everywhere – From Customers Who Have” on June 29 at 4:30 p.m.

*These statements were verified using Carestream detectors in a reader study performed by board certified radiologists comparing pairwise images taken at nominal dose (CsI ISO 400 speed / GOS ISO 320 speed) and reduced dose (CsI ISO 800 speed / GOS ISO 500 speed) with SNC. This study led to an FDA 510k clearance of SNC for dose reduction.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”